Alzheimer's researchers and drug companies have for years concentrated on one hallmark of Alzheimer’s disease: the production of toxic shards of a protein that accumulate in plaques on the brain.
- Education, Training & Outreach
- Patients & Caregivers
- For Investigators
- Dementia in the News
- Media Room